Anti-Angiotensinogen/AGT Antibody Picoband®

AGT antibody

Boster Bio Anti-Angiotensinogen/AGT Antibody Picoband® catalog # A02103-4. Tested in ELISA, IHC, WB, Flow Cytometry applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Product Info Summary

SKU: A02103-4
Size: 100 µg/vial
Reactive Species: Human
Host: Rabbit
Application: ELISA, Flow Cytometry, IHC, WB

Customers Who Bought This Also Bought

Product Name

Anti-Angiotensinogen/AGT Antibody Picoband®

View all AGT Antibodies

SKU/Catalog Number

A02103-4

Size

100 µg/vial

Form

Lyophilized

Description

Boster Bio Anti-Angiotensinogen/AGT Antibody Picoband® catalog # A02103-4. Tested in ELISA, IHC, WB, Flow Cytometry applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Storage & Handling

At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.

Cite This Product

Anti-Angiotensinogen/AGT Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # A02103-4)

Host

Rabbit

Contents

Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Clonality

Polyclonal

Isotype

Rabbit IgG

Immunogen

E.coli-derived human Angiotensinogen/AGT recombinant protein (Position: D273-R458).

Cross-reactivity

No cross-reactivity with other proteins

Reactive Species

A02103-4 is reactive to AGT in Human

Observed Molecular Weight

53 kDa

Calculated molecular weight

53.2 kDa

Background of AGT

AGT(ANGIOTENSINOGEN), also called SERPINA8, is an α-2-globulin that is produced constitutively and released into the circulation mainly by the liver. ATG is a member of the serpin family, although it is not known to inhibit other enzymes, unlike most serpins. Angiotensinogen is also known as renin substrate. The AGT gene is mapped on 1q42.2. And the human angiotensinogen gene contains 5 exons. The expression of AGT and enzymes required for its conversion to angiotensin II in human adipose tissue. Mutations in this AGT gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

A02103-4 is guaranteed for ELISA, Flow Cytometry, IHC, WB Boster Guarantee

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.

Western blot, 0.1-0.25 μg/ml, Human
Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/ml, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/ml, -

Positive Control

WB: human hepatocellular carcinoma tumor tissue (HCCT), human hepatocellular carcinoma paracancerous tissue (HCCP), human HepG2 whole cell, human HUH-7 whole cell
IHC: human lung adenocarcinoma tissue, human rectum adenocarcinoma tissue
FCM: HepG2 cell

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-Angiotensinogen/AGT Antibody Picoband®?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-Angiotensinogen/AGT Antibody Picoband®

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-Angiotensinogen/AGT Antibody Picoband®

Order DetailsPrice
A02103-4

100μg

$370
A02103-4-Fluoro488

100 μg Fluoro488 conjugated (liquid)

$570
A02103-4-Fluoro550

100 μg Fluoro550 conjugated (liquid)

$570
A02103-4-Fluoro594

100 μg Fluoro594 conjugated (liquid)

$570
A02103-4-Fluoro647

100 μg Fluoro647 conjugated (liquid)

$670
A02103-4-APC

100 μg APC conjugated (liquid)

$820
A02103-4-FITC

100 μg FITC conjugated (liquid)

$570
A02103-4-Cy3

100 μg Cy3 conjugated (liquid)

$570
A02103-4-Biotin

100 μg Biotin conjugated (liquid)

$570
A02103-4-HRP

100 μg HRP conjugated (liquid)

$570
A02103-4-PE

100 μg PE conjugated (liquid)

$820
A02103-4-carrier-free

Carrier Free

$370
Rainbow Button View conjugates

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$65.00  $130.00
$67.50  $135.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
$55.00  $110.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
A02103-4
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Apr 12, 2026